Skip to main content
. 2018 Aug;10(8):5080–5085. doi: 10.21037/jtd.2018.07.138

Table 2. Sensitivities in non-small cell lung cancer.

Characteristic miRNAs positive Total patients Sensitivity (%)
Atypical adenomatoid hyperplasia 7 46 15.2
Adenocarcinoma in situ 37 107 34.5
Invasive adenocarcinoma 38 85 44.7
Others 2 9 22.2
Total patients 84 247 34.0